Sarcolemmal Specific Collagen VI Deficient Myopathy in a Labrador Retriever

Journal of Veterinary Internal Medicine

Volumn 28, Issue 1, 2014, Pages 243-249

  Marioni Henry, K ^a   Haworth, P ^b   Scott, H ^a   Witte, P ^a   Guo, L T ^c   Diane Shelton, G ^c  

^a Forest Corner Farm   (United Kingdom)

^b New Era Veterinary Hospital   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Carpal and tarsal hyperextension; Dog; Joint deformities; Muscular dystrophy

Indexed keywords

CANIS FAMILIARIS;

COLLAGEN TYPE 6;

ANIMAL; ANIMAL DISEASE; ARTICLE; CARPAL AND TARSAL HYPEREXTENSION; CASE REPORT; DOG; DOG DISEASE; ENZYMOLOGY; FEMALE; GAIT; JOINT; JOINT DEFORMITIES; MUSCLE DISEASE; MUSCULAR DYSTROPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; SARCOLEMMA; ULTRASTRUCTURE;

CARPAL AND TARSAL HYPEREXTENSION; DOG; JOINT DEFORMITIES; MUSCULAR DYSTROPHY;

ANIMALS; COLLAGEN TYPE VI; DOG DISEASES; DOGS; FEMALE; GAIT; JOINTS; MUSCULAR DISEASES; SARCOLEMMA;

EID: 84892485065     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/jvim.12224     Document Type: Article

References (21)

1. Pele M, Tiret L, Kessler J-L, et al. SINE exonic insertion in the PTPLA gene leads to multiple splicing defects and segregates with the autosomal recessive centronuclear myopathy in dogs. Hum Mol Genet 2005;14:1417-1427.
2. Lee AF, Bowen JM. Evaluation of motor nerve conduction velocity in the dog. Am J Vet Res 1970;31:1361-1366.
3. Dubowitz V, Sewry CA. Histological and histochemical stains and reactions. Dubowitz V, Sewry CA, ed. Muscle Biopsy: A Practical Approach, 3rd ed. London: Saunders Elsevier; 2007:21-39.
4. Zi-Fang L, Wu X, Jiang Y, et al. Non-pathogenic protein aggregates in skeletal muscle in MLF1 transgenic mice. J Neurol Sci 2008;264:77-86.
5. Jaegger G, Marcellin-Little DJ, Levine D. Reliability of goniometry in Labrador Retrievers. Am J Vet Res 2002;63:979-986.
6. Bönneman CG. The collagen VI-related myopathies: Muscle meets its matrix. Nat Rev Neurol 2011;7:379-390.
7. Voit T, Tome FM. The congenital muscular dystrophies. Engel AG, Franzini-Armstrong C, eds. Myology, Basic and Clinical, 3rd ed. New York, NY: McGraw-Hill; 2004:1230.
8. Quijano-Roy S, Renault F, Romero N, et al. EMG and nerve conduction studies in children with congenital muscle dystrophy. Muscle Nerve 2004;29:292-299.
9. Dubowitz V, Sewry CA. Congenital myopathies. Dubowitz V, Sewry CA, ed. Muscle Biopsy: A Practical Approach, 3rd ed. London: Saunders Elsevier; 2007:407-442.
10. Kuo HJ, Maslen CL, Keene DR, et al. Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. J Biol Chem 1997;272:26522-26529.
11. Ishikawa H, Sugie K, Murayama K, et al. Ullrich disease: Collagen VI deficiency: EM suggests a new basis for muscular weakness. Neurology 2002;59:920-923.
12. Ishikawa H, Sugie K, Murayama K, et al. Ullrich disease due to deficiency of collagen VI in the sarcolemma. Neurology 2004;62:620-623.
13. Kawahara G, Okada M, Morone N, et al. Reduced cell anchorage may cause sarcolemma-specific collagen VI deficiency in Ullrich disease. Neurology 2007;69:1043-1049.
14. Bonaldo P, Braghetta P, Zanetti M, et al. Collagen VI deficiency induces early onset myopathy in the mouse: An animal model for Bethlem myopathy. Hum Mol Genet 1998;7:2135-2140.
15. Allamand V, Briñas L, Richard P, et al. ColVI myopathies: Where do we stand, where do we go? Skelet Muscle 2011;1:30.
16. Telfer WR, Busta AS, Bonnemann CG, et al. Zebrafish models of collagen VI-related myopathies. Hum Mol Genet 2010;19:2433-2444.
17. Merlini L, Angelin A, Tiepolo T, et al. Cyclosporin A corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathies. Proc Natl Acad Sci USA 2008;105:5225-5229.
18. Merlini L, Sabatelli P, Armaroli A, et al. Cyclosporine A in Ullrich congenital muscular dystrophy: Long-term results. Oxid Med Cell Longev 2011;2011:139194.
19. Muñana KR, Zhang D, Patterson EE. Placebo effect in canine epilepsy trials. J Vet Intern Med 2010;24:166-170.
20. Fenichel GM, Griggs RC, Kissel J, et al. A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy. Neurology 2001;56:1075-1079.
21. Shelton GD, Engvall E. Canine and feline models of human inherited muscle diseases. Neuromuscul Disord 2005;15:127-138.